Clarivate PLC (NYSE:CLVT) Receives Consensus Recommendation of “Reduce” from Analysts

Posted by Brian Himes on Jul 5th, 2026

Shares of Clarivate PLC (NYSE:CLVT – Get Free Report) have been given a consensus rating of “Reduce” by the eight research firms that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation and five have assigned a hold recommendation to the company. The average 1 year target price among analysts that have covered the stock in the last year is $3.2167.

A number of research firms recently issued reports on CLVT. Weiss Ratings reiterated a “sell (e+)” rating on shares of Clarivate in a report on Wednesday, June 24th. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd.

View Our Latest Research Report on Clarivate

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of CLVT. Personal CFO Solutions LLC acquired a new position in Clarivate during the first quarter worth $30,000. FreeGulliver LLC acquired a new stake in Clarivate in the first quarter valued at $30,000. Principal Financial Group Inc. bought a new position in shares of Clarivate in the 1st quarter valued at about $32,000. M&T Bank Corp acquired a new position in shares of Clarivate during the 4th quarter worth about $34,000. Finally, Parallel Advisors LLC lifted its stake in Clarivate by 94.2% in the 1st quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock valued at $35,000 after purchasing an additional 6,687 shares during the last quarter. 85.72% of the stock is currently owned by institutional investors.

Clarivate Stock Down 0.6%

Shares of CLVT stock opened at $2.58 on Friday. Clarivate has a 12-month low of $1.66 and a 12-month high of $4.77. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.89. The firm has a fifty day moving average of $2.41 and a 200-day moving average of $2.58. The company has a market capitalization of $1.65 billion, a price-to-earnings ratio of -12.26 and a beta of 1.38.

Clarivate (NYSE:CLVT – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.14 by $0.04. The business had revenue of $585.50 million for the quarter, compared to analysts’ expectations of $569.50 million. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The firm’s revenue was down 1.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.14 EPS. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, equities research analysts predict that Clarivate will post 0.65 earnings per share for the current fiscal year.

About Clarivate

(Get Free Report)

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.